Study: Stem cell transplants reduce diabetics' insulin reliance

04/14/2009 | Yahoo!

In a U.S. study, 20 of 23 patients with Type 1 diabetes did not need to take daily insulin therapy for four years after receiving transplants of bone marrow-derived stem cells. The study also found that the patients were able to maintain the increase in levels of C-peptides, an indicator for insulin production, for at least three years.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN